- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Programmed Cell Death-Ligand 1 (PD-L1)
Total 91761 results
-
Jounce Therapeutics, Inc.Completed
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing... and other collaboratorsNot yet recruitingCervical Cancer | Locally Advanced Cervical Cancer | PD-L1 Negative | Neoadjuvant ChemoimmunotherapyChina
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced Hepatocellular CarcinomaChina
-
University Medical Center GroningenRecruiting
-
Agenus Inc.Terminated
-
Merck Sharp & Dohme LLCTerminated
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
AstraZenecaRecruitingBiliary Tract CancerFrance, Spain, Italy, Korea, Republic of, Japan, Germany, United States, Singapore
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Non-Small Lung Cell Cancer | Recurrent Non-Small Lung Cell CancerUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingAdvanced Solid TumorsChina
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Shenzhen Geno-Immune Medical InstituteEnrolling by invitationGlioblastoma Multiforme | Glioblastoma Multiforme of BrainChina
-
Chugai PharmaceuticalCompleted
-
Xijing HospitalRecruitingPD-1 | Locally Advanced Gastric AdenocarcinomaChina
-
University of Colorado, DenverAstraZenecaWithdrawnPancreatic CancerUnited States
-
Chinese PLA General HospitalRecruitingLymphoma | Solid TumorChina
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Swiss Group for Clinical Cancer ResearchActive, not recruiting
-
Mahmoud Ramadan mohamed ElkazzazNot yet recruiting
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
Regeneron PharmaceuticalsNot yet recruitingMelanoma | Advanced Solid Tumors | Clear-Cell Renal-Cell Carcinoma (ccRCC)
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Arrys TherapeuticsMerck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer AdenocarcinomaUnited States
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
BeiGeneActive, not recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma (HNSCC) | Nasopharyngeal Carcinoma (NPC)Canada, Australia, New Zealand, Korea, Republic of, United States, Malaysia, Thailand
-
Instituto Portugues de Oncologia, Francisco Gentil...AstraZenecaRecruiting
-
Andrew SharabiPfizerTerminatedEarly Stage Non-Small Cell Lung CancerUnited States
-
Regeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Israel
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Hunan Cancer HospitalCompleted
-
Incyte CorporationTerminatedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, Bulgaria, Hungary, Taiwan, Ukraine
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
Wuhan Union Hospital, ChinaRecruitingGastroesophageal Junction Cancer | PD-1 | Neoadjuvant ChemoradiotherapyChina
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
National Cancer Institute (NCI)Not yet recruitingHead and Neck Cancer | Lung Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Non-small Cell Lung Cancer | Sinonasal Cancer | Head and Neck CarcnimonaUnited States
-
TransgenePfizer; EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt...Active, not recruitingHPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV-Related Anal Squamous Cell Carcinoma | HPV-Related Penile Squamous Cell Carcinoma | HPV-Related Vulvar Squamous Cell CarcinomaUnited States, France, Spain
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaChina
-
The First Hospital of Jilin UniversityRecruitingPD-L1 Positive Locally Advanced Patients With Resectable Gastric CancerChina
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada, France, Italy, Spain, United Kingdom, Poland, Taiwan, Thailand, Vietnam, Belgium, Germany, Korea, Republic of, Brazil, India, Japan, Philippines, Russian Federation, Austria, Ukraine, Greece, Slovakia, Romania
-
University of California, San DiegoMerck Sharp & Dohme LLCActive, not recruitingHead and Neck Cancer | Head and Neck Neoplasms | Nasopharynx Cancer | Head and Neck Squamous Cell Carcinoma | Oropharynx Cancer | Oral Cavity Cancer | Larynx Cancer | HNSCC | Hypopharynx Cancer | Cutaneous Squamous Cell Carcinoma | Lip SCC | Sinonasal CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Istari Oncology, Inc.Active, not recruiting
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular CarcinomaChina